English

Zymeworks Inc.

EDGAR

ZYME Quarterly report (10-Q) · filed 2022-08-04

49 filing records in this dataset, filed from 2017-04-03 to 2022-08-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.44 million USD

2022 Q2 · USD

Exact inputs and evidence

Revenue: 5442000 USD Source

Operating margin

-1,209.54%

2022 Q2 · %

Exact inputs and evidence

Operating Income: -65823000 USD Source
Revenue: 5442000 USD Source

Operating cash flow

-54.8 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -110236000 USD Source
Operating Cash Flow: -55412000 USD Source

Free cash flow

-57.5 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -110236000 USD Source
Operating Cash Flow: -55412000 USD Source
Capital Expenditure: 6821000 USD Source
Capital Expenditure: 4158000 USD Source

Cash and cash equivalents: 199 million USD 2022-06-30 Source
Exact value

198649000 USD
Long-term debt including current maturities: 4.7 million USD 2017-12-31 Source
Exact value

4700000 USD
Shares outstanding: 57.8 million shares 2022-06-30 Source
Exact value

57772461 shares

Reported share-count change

24.95% · 11.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46234737 shares · 2021-06-30· Source
57772461 shares · 2022-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

31.6 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Revenue: 4395000 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 26680000 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 6810000 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 1916000 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 5442000 USD · 2022-04-01 – 2022-06-30 Source

Net income

-237 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Net income: -60579000 USD · 2021-07-01 – 2021-09-30 Source
Net income: -211843000 USD · 2021-01-01 – 2021-12-31 Source
Net income: -172691000 USD · 2021-01-01 – 2021-09-30 Source
Net income: -72625000 USD · 2022-01-01 – 2022-03-31 Source
Net income: -64619000 USD · 2022-04-01 – 2022-06-30 Source

Operating cash flow

-212 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -141942000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -91155000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -192451000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -141942000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -55412000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -110236000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -55412000 USD · 2022-01-01 – 2022-03-31 Source

Capital expenditure

16.8 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Capital expenditure: 7621000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 2447000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 12404000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 7621000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 4158000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 6821000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 4158000 USD · 2022-01-01 – 2022-03-31 Source

Free cash flow

-228 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -141942000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -91155000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -192451000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -141942000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -55412000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -110236000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -55412000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 7621000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 2447000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 12404000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 7621000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 4158000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 6821000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 4158000 USD · 2022-01-01 – 2022-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-08-04.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2021-12-31
Operating income: 6 of 11 periods available· newest 2021-12-31
Net income: 6 of 11 periods available· newest 2021-12-31
Operating cash flow: 6 of 11 periods available· newest 2021-12-31
Capital expenditure: 6 of 11 periods available· newest 2021-12-31
Total assets: 3 of 11 periods available· newest 2021-12-31
Total liabilities: 3 of 11 periods available· newest 2021-12-31
Current assets: 3 of 11 periods available· newest 2021-12-31
Current liabilities: 3 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-31.5%

Prior period

USD 38.95 million

2020-01-01 – 2020-12-31
Current period

USD 26.68 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

26680000 − 38951000 = -12271000 USD

38951000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
26680000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Year-over-year change in Revenue: -12271000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 26680000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#2085590 Filing: 000140375222000005 Input fundies:Revenue: 38951000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#2086986 Filing: 000140375222000005
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 31.29 million

Prior period

−USD 180.55 million

2020-01-01 – 2020-12-31
Current period

−USD 211.84 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-211843000 − -180552000 = -31291000 USD

-180552000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-211843000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Year-over-year change in Net income: -31291000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -211843000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1365186 Filing: 000140375222000005 Input fundies:NetIncome: -180552000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1334156 Filing: 000140375222000005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 41.05 million

Prior period

−USD 151.4 million

2020-01-01 – 2020-12-31
Current period

−USD 192.45 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-192451000 − -151403000 = -41048000 USD

-151403000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-192451000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Year-over-year change in Operating cash flow: -41048000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -192451000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1434676 Filing: 000140375222000005 Input fundies:OperatingCashFlow: -151403000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1435958 Filing: 000140375222000005
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+187.8%

Prior period

USD 4.31 million

2020-01-01 – 2020-12-31
Current period

USD 12.4 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

12404000 − 4310000 = 8094000 USD

4310000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
12404000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Year-over-year change in Capital expenditure: 8094000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12404000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1465962 Filing: 000140375222000005 Input fundies:CapitalExpenditure: 4310000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1466944 Filing: 000140375222000005
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 26.68 million 100% of revenue
Operating costs Derived USD 242.31 million 908% of revenue
Operating income −USD 215.63 million −808% of revenue
Tax, interest and other Derived −USD 3.79 million −14% of revenue
Net income −USD 211.84 million −794% of revenue

Cash

Operating cash flow −USD 192.45 million −721% of revenue
Capital expenditure USD 12.4 million 46% of revenue
Free cash flow Derived −USD 204.86 million −768% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 612% of revenue.
2020 Operating loss: operating costs were 581% of revenue.
2021 Operating loss: operating costs were 908% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	29544000	180845000 Derived	-151301000	-5864000 Derived	-145437000	-88175000 Derived	Source 2019-01-01 – 2019-12-31: 29544000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -151301000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -145437000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -81853000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 6322000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	38951000	226419000 Derived	-187468000	-6916000 Derived	-180552000	-155713000 Derived	Source 2020-01-01 – 2020-12-31: 38951000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -187468000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -180552000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -151403000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 4310000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	26680000	242313000 Derived	-215633000	-3790000 Derived	-211843000	-204855000 Derived	Source 2021-01-01 – 2021-12-31: 26680000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -215633000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -211843000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -192451000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 12404000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 26.7M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	29544000	Revenue: 29544000 Open source
20202020-12-31	Revenue	38951000	Revenue: 38951000 Open source
20212021-12-31	Revenue	26680000	Revenue: 26680000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-31.5% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 29544000 Open source
20202020-12-31	Year over year	31.8%	Revenue: 38951000 Open source Revenue: 29544000 Open source
20212021-12-31	Year over year	-31.5%	Revenue: 26680000 Open source Revenue: 38951000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -808.2% 2021

Net margin -794% 2021

Free cash flow margin -767.8% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-512.1%	Operating Income: -151301000 Open source Revenue: 29544000 Open source
20202020-12-31	Operating margin	-481.3%	Operating Income: -187468000 Open source Revenue: 38951000 Open source
20212021-12-31	Operating margin	-808.2%	Operating Income: -215633000 Open source Revenue: 26680000 Open source
20192019-12-31	Net margin	-492.3%	Net Income: -145437000 Open source Revenue: 29544000 Open source
20202020-12-31	Net margin	-463.5%	Net Income: -180552000 Open source Revenue: 38951000 Open source
20212021-12-31	Net margin	-794%	Net Income: -211843000 Open source Revenue: 26680000 Open source
20192019-12-31	Free cash flow margin	-298.5%	Revenue: 29544000 Open source Operating Cash Flow: -81853000 Open source Capital Expenditure: 6322000 Open source
20202020-12-31	Free cash flow margin	-399.8%	Revenue: 38951000 Open source Operating Cash Flow: -151403000 Open source Capital Expenditure: 4310000 Open source
20212021-12-31	Free cash flow margin	-767.8%	Revenue: 26680000 Open source Operating Cash Flow: -192451000 Open source Capital Expenditure: 12404000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -192.5M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-81853000	Operating Cash Flow: -81853000 Open source
20202020-12-31	Operating cash flow	-151403000	Operating Cash Flow: -151403000 Open source
20212021-12-31	Operating cash flow	-192451000	Operating Cash Flow: -192451000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -204.9M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-88175000	Operating Cash Flow: -81853000 Open source Capital Expenditure: 6322000 Open source
20202020-12-31	Free cash flow	-155713000	Operating Cash Flow: -151403000 Open source Capital Expenditure: 4310000 Open source
20212021-12-31	Free cash flow	-204855000	Operating Cash Flow: -192451000 Open source Capital Expenditure: 12404000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	33.3%	Total Liabilities: 122524000 Open source Total Assets: 368205000 Open source
20202020-12-31	Liabilities / assets	23.9%	Total Liabilities: 128454000 Open source Total Assets: 538376000 Open source
20212021-12-31	Liabilities / assets	36%	Total Liabilities: 140038000 Open source Total Assets: 389132000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.01× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	3.78×	Current Assets: 311830000 Open source Current Liabilities: 82552000 Open source
20202020-12-31	Current assets / current liabilities	5.31×	Current Assets: 455076000 Open source Current Liabilities: 85666000 Open source
20212021-12-31	Current assets / current liabilities	4.01×	Current Assets: 288220000 Open source Current Liabilities: 71853000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 33.81 million Exact value Exact value: -33809000 USD 2016-01-01 – 2016-12-31: -33809000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2016-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -33809000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33809000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/zyme-20181231.xml#1693025 Filing: 000119312519065609 The citation records this snapshot. The page link may show a newer release later.	−USD 35.25 million Exact value Exact value: -35246000 USD 2016-01-01 – 2016-12-31: -35246000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2016-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: -35246000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35246000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/zyme-20181231.xml#1692756 Filing: 000119312519065609 The citation records this snapshot. The page link may show a newer release later.	USD 4.43 million Exact value Exact value: 4425000 USD 2016-01-01 – 2016-12-31: 4425000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2016-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 4425000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4425000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/zyme-20181231.xml#1694255 Filing: 000119312519065609 The citation records this snapshot. The page link may show a newer release later.	−USD 39.67 million Calculation and evidence -35246000 − 4425000 USD Exact free cash flow: -39671000 USD 2016-01-01 – 2016-12-31: -35246000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 4425000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2016-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: -39671000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35246000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/zyme-20181231.xml#1692756 Filing: 000119312519065609 Input fundies:CapitalExpenditure: 4425000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/zyme-20181231.xml#1694255 Filing: 000119312519065609 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 10.41 million Exact value Exact value: -10406000 USD 2017-01-01 – 2017-12-31: -10406000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2017-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -10406000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10406000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/d829510d10k.htm#2581727 Filing: 000119312520058902 The citation records this snapshot. The page link may show a newer release later.	USD 219,000 Exact value Exact value: 219000 USD 2017-01-01 – 2017-12-31: 219000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2017-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: 219000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 219000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/d829510d10k.htm#2256234 Filing: 000119312520058902 The citation records this snapshot. The page link may show a newer release later.	USD 2.02 million Exact value Exact value: 2015000 USD 2017-01-01 – 2017-12-31: 2015000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2017-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 2015000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2015000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/d829510d10k.htm#2348327 Filing: 000119312520058902 The citation records this snapshot. The page link may show a newer release later.	−USD 1.8 million Calculation and evidence 219000 − 2015000 USD Exact free cash flow: -1796000 USD 2017-01-01 – 2017-12-31: 219000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2015000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2017-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: -1796000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 219000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/d829510d10k.htm#2256234 Filing: 000119312520058902 Input fundies:CapitalExpenditure: 2015000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/d829510d10k.htm#2348327 Filing: 000119312520058902 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 36.56 million Exact value Exact value: -36556000 USD 2018-01-01 – 2018-12-31: -36556000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2018-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -36556000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36556000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375221000005/zyme-20201231.htm#1296933 Filing: 000140375221000005 The citation records this snapshot. The page link may show a newer release later.	USD 24.18 million Exact value Exact value: 24177000 USD 2018-01-01 – 2018-12-31: 24177000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2018-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: 24177000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24177000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375221000005/zyme-20201231.htm#1437749 Filing: 000140375221000005 The citation records this snapshot. The page link may show a newer release later.	USD 803,000 Exact value Exact value: 803000 USD 2018-01-01 – 2018-12-31: 803000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2018-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 803000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 803000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375221000005/zyme-20201231.htm#1468224 Filing: 000140375221000005 The citation records this snapshot. The page link may show a newer release later.	USD 23.37 million Calculation and evidence 24177000 − 803000 USD Exact free cash flow: 23374000 USD 2018-01-01 – 2018-12-31: 24177000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 803000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2018-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: 23374000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24177000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375221000005/zyme-20201231.htm#1437749 Filing: 000140375221000005 Input fundies:CapitalExpenditure: 803000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375221000005/zyme-20201231.htm#1468224 Filing: 000140375221000005 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 145.44 million Exact value Exact value: -145437000 USD 2019-01-01 – 2019-12-31: -145437000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2019-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -145437000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -145437000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1299650 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 81.85 million Exact value Exact value: -81853000 USD 2019-01-01 – 2019-12-31: -81853000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2019-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: -81853000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81853000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1437240 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	USD 6.32 million Exact value Exact value: 6322000 USD 2019-01-01 – 2019-12-31: 6322000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2019-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 6322000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6322000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1467925 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 88.18 million Calculation and evidence -81853000 − 6322000 USD Exact free cash flow: -88175000 USD 2019-01-01 – 2019-12-31: -81853000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 6322000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2019-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: -88175000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81853000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1437240 Filing: 000140375222000005 Input fundies:CapitalExpenditure: 6322000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1467925 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 180.55 million Exact value Exact value: -180552000 USD 2020-01-01 – 2020-12-31: -180552000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2020-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -180552000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -180552000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1334156 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 151.4 million Exact value Exact value: -151403000 USD 2020-01-01 – 2020-12-31: -151403000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2020-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: -151403000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -151403000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1435958 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	USD 4.31 million Exact value Exact value: 4310000 USD 2020-01-01 – 2020-12-31: 4310000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2020-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 4310000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4310000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1466944 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 155.71 million Calculation and evidence -151403000 − 4310000 USD Exact free cash flow: -155713000 USD 2020-01-01 – 2020-12-31: -151403000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4310000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2020-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: -155713000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -151403000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1435958 Filing: 000140375222000005 Input fundies:CapitalExpenditure: 4310000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1466944 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 211.84 million Exact value Exact value: -211843000 USD 2021-01-01 – 2021-12-31: -211843000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Net Income: -211843000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -211843000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1365186 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 192.45 million Exact value Exact value: -192451000 USD 2021-01-01 – 2021-12-31: -192451000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Operating Cash Flow: -192451000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -192451000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1434676 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	USD 12.4 million Exact value Exact value: 12404000 USD 2021-01-01 – 2021-12-31: 12404000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Capital Expenditure: 12404000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12404000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1465962 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.	−USD 204.86 million Calculation and evidence -192451000 − 12404000 USD Exact free cash flow: -204855000 USD 2021-01-01 – 2021-12-31: -192451000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 12404000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zymeworks Inc. · 2021-12-31 Zymeworks Inc. (edgar:1403752) Free cash flow: -204855000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:58:02Z Snapshot: 96cc988a26d94258da6b97ba388be1bedabe584900b2226ea479521ad822a959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1403752?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -192451000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1434676 Filing: 000140375222000005 Input fundies:CapitalExpenditure: 12404000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1403752/000140375222000005/zyme-20211231.htm#1465962 Filing: 000140375222000005 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 1,338 latest values · 1,338 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001403752, 1403752, ZYME, edgar:1403752

Also known as ZYMEWORKS INC., Zymeworks BC Inc., Zymeworks Inc, Zymeworks Inc.

Zymeworks Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation